Carpenter JT - Search Results

1

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.

Harris BE, Carpenter JT, Diasio RB. Harris BE, et al. Among authors: carpenter jt. Cancer. 1991 Aug 1;68(3):499-501. doi: 10.1002/1097-0142(19910801)68:3<499::aid-cncr2820680309>3.0.co;2-f. Cancer. 1991. PMID: 1648430

2

Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Diasio RB, Beavers TL, Carpenter JT. Diasio RB, et al. Among authors: carpenter jt. J Clin Invest. 1988 Jan;81(1):47-51. doi: 10.1172/JCI113308. J Clin Invest. 1988. PMID: 3335642 Free PMC article.

3

Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy.

Lu Z, Zhang R, Carpenter JT, Diasio RB. Lu Z, et al. Among authors: carpenter jt. Clin Cancer Res. 1998 Feb;4(2):325-9. Clin Cancer Res. 1998. PMID: 9516918 Clinical Trial.

4

Weight gain with breast cancer adjuvant treatment.

Levine EG, Raczynski JM, Carpenter JT. Levine EG, et al. Among authors: carpenter jt. Cancer. 1991 Apr 1;67(7):1954-9. doi: 10.1002/1097-0142(19910401)67:7<1954::aid-cncr2820670722>3.0.co;2-z. Cancer. 1991. PMID: 2004310

5

The use of anthracyclines in the adjuvant treatment of breast cancer.

Lowenthal EA, Carpenter JT Jr. Lowenthal EA, et al. Among authors: carpenter jt jr. Cancer Treat Rev. 1995 May;21(3):199-214. doi: 10.1016/0305-7372(95)90001-2. Cancer Treat Rev. 1995. PMID: 7656265 Review. No abstract available.

6

A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for breast cancer.

Silvey L, Carpenter JT Jr, Wheeler RH, Lee J, Conolley C. Silvey L, et al. Among authors: carpenter jt jr. J Clin Oncol. 1988 Sep;6(9):1397-400. doi: 10.1200/JCO.1988.6.9.1397. J Clin Oncol. 1988. PMID: 3047334 Clinical Trial.

7

Favorable factors in the adjuvant therapy of breast cancer.

Carpenter JT Jr, Maddox WA, Laws HL, Wirtschafter DD, Soong SJ. Carpenter JT Jr, et al. Cancer. 1982 Jul 1;50(1):18-23. doi: 10.1002/1097-0142(19820701)50:1<18::aid-cncr2820500105>3.0.co;2-j. Cancer. 1982. PMID: 7044517 Clinical Trial.

8

Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.

Christian ES, Schreeder M, Salter MM, Stephens SB, Carpenter JT Jr, Wheeler RH. Christian ES, et al. Among authors: carpenter jt jr. Am J Clin Oncol. 1988 Aug;11(4):502-5. doi: 10.1097/00000421-198808000-00018. Am J Clin Oncol. 1988. PMID: 2841845

9

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.

Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S. Smalley RV, et al. Cancer. 1977 Aug;40(2):625-32. doi: 10.1002/1097-0142(197708)40:2<625::aid-cncr2820400206>3.0.co;2-m. Cancer. 1977. PMID: 329975 Clinical Trial.

10

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.

Smalley RV, Lefante J, Bartolucci A, Carpenter J, Vogel C, Krauss S. Smalley RV, et al. Breast Cancer Res Treat. 1983;3(2):209-20. doi: 10.1007/BF01803563. Breast Cancer Res Treat. 1983. PMID: 6688538 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters